THE WHAT? Hamburg Airport has become the first major commercial airport in Germany to achieve CO2-neutral operations, therefore satisfying the Airport Council International Europe (ACI) for certification of CO2 neutrality.
THE DETAILS Michael Eggenschwiler, CEO of Hamburg Airport, was issued the verification of achieving CO2 neutrality according to Airport Carbon Accreditation guidelines this month.
The biggest airport in Northern Germany is said to be building on its role as a pioneer in climate protection, with a press release stating, “building blocks of CO2-neutral airport operations are: reduced energy consumption, innovative technologies, conservation projects, and high quality offset certificates.”
THE WHY? Numerous internal measures and woodland projects were made in order to achieve the verification status, with Hamburg Airport continuously optimising its technical building infrastructure, for example with efficient ventilation and air-conditioning facilities, the expansion of the site heating network, and the conversion to LED lighting, which saves emissions through significant reductions in energy consumption in the terminals and on the operational areas.
Eggenschwiler said, “Despite the economic difficulties arising from the coronavirus pandemic, we have pursued our climate protection goals as a top priority. We are thrilled to be the first major airport in Germany to achieve CO2 neutrality.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
